Revance Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 8.60 M | $26.14 M | -1.49% | 8.25% |
| BERYL CAPITAL MANAGEMENT LLC | 02/14/2025 | 5.94 M | $18.04 M | 100.00% | 5.70% |
| VANGUARD GROUP INC | 02/11/2025 | 5.63 M | $17.10 M | -1.89% | 5.40% |
| 02/12/2025 | 5.10 M | $15.50 M | 603.45% | 4.89% | |
| FIL LTD | 02/13/2025 | 4.20 M | $12.76 M | 0.08% | 4.03% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 3.50 M | $10.63 M | 7.26% | 3.36% |
| SQUAREPOINT OPS LLC | 02/14/2025 | 3.16 M | $9.62 M | 37.03% | 3.04% |
| METEORA CAPITAL, LLC | 02/14/2025 | 2.87 M | $8.72 M | 100.00% | 2.75% |
| MAGNETAR FINANCIAL LLC | 02/11/2025 | 2.56 M | $7.77 M | 2.25% | 2.45% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 02/07/2025 | 2.35 M | $7.14 M | -43.55% | 2.26% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 2.30 M | $6.99 M | 0.35% | 2.20% |
| GLAZER CAPITAL, LLC | 02/14/2025 | 1.95 M | $5.93 M | 100.00% | 1.87% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 1.87 M | $5.67 M | 100.00% | 1.79% |
| NEWTYN MANAGEMENT, LLC | 02/14/2025 | 1.81 M | $5.50 M | 100.00% | 1.74% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 1.65 M | $5.03 M | 57.49% | 1.59% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 1.55 M | $4.72 M | 949.57% | 1.49% |
| UBS GROUP AG | 02/14/2025 | 1.48 M | $4.51 M | 134.45% | 1.42% |
| AQR ARBITRAGE LLC | 02/14/2025 | 1.41 M | $4.30 M | 0.00% | 1.36% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 1.37 M | $4.16 M | -29.23% | 1.31% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 1.33 M | $4.04 M | -29.75% | 1.27% |
| JPMORGAN CHASE & CO | 02/12/2025 | 1.30 M | $3.95 M | 867.96% | 1.25% |
| GABELLI FUNDS LLC | 02/13/2025 | 1.26 M | $3.84 M | 15.70% | 1.21% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 1.16 M | $3.53 M | -75.73% | 1.11% |
| GABELLI & CO INVESTMENT ADVISERS, INC. | 02/13/2025 | 1.06 M | $3.22 M | 26.04% | 1.02% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 812,927 | $2.47 M | -30.12% | 0.78% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 797,299 | $2.42 M | 0.82% | 0.77% |
| WATER ISLAND CAPITAL LLC | 02/13/2025 | 722,234 | $2.20 M | -69.67% | 0.69% |
| RICE HALL JAMES & ASSOCIATES, LLC | 01/31/2025 | 678,541 | $2.06 M | -7.07% | 0.65% |
| SLOTNIK CAPITAL, LLC | 02/12/2025 | 671,607 | $2.04 M | 100.00% | 0.64% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 02/14/2025 | 551,224 | $1.68 M | 100.00% | 0.53% |
| FNY INVESTMENT ADVISERS, LLC | 01/13/2025 | 477,823 | $1.45 M | 160.39% | 0.46% |
| ESSEX WOODLANDS MANAGEMENT, INC. | 02/13/2025 | 457,085 | $1.39 M | 0.00% | 0.44% |
| MAN GROUP PLC | 02/14/2025 | 443,544 | $1.35 M | 47.85% | 0.43% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 423,189 | $1.29 M | -7.06% | 0.41% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/14/2025 | 414,310 | $1.26 M | 176.21% | 0.40% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 411,523 | $1.25 M | -7.74% | 0.39% |
| BARCLAYS PLC | 02/13/2025 | 402,691 | $1.23 M | 132.29% | 0.39% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 400,000 | $1.22 M | 4,900.00% | 0.38% |
| 02/14/2025 | 360,000 | $1.09 M | 100.00% | 0.35% | |
| VAZIRANI ASSET MANAGEMENT LLC | 02/14/2025 | 350,000 | $1.06 M | 250.00% | 0.34% |
| LMR PARTNERS LLP | 02/14/2025 | 347,207 | $1.06 M | -84.53% | 0.33% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 307,764 | $935,603 | -5.68% | 0.30% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 303,073 | $921,342 | 435.17% | 0.29% |
| CANDRIAM S.C.A. | 02/07/2025 | 299,039 | $909,079 | 100.00% | 0.29% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/12/2025 | 297,458 | $904,000 | 137.97% | 0.29% |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | 02/05/2025 | 295,670 | $898,837 | 114.89% | 0.28% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 293,675 | $892,773 | 27.35% | 0.28% |
| MARSHALL WACE, LLP | 02/13/2025 | 252,468 | $767,504 | -55.50% | 0.24% |
| METEORA CAPITAL, LLC | 02/14/2025 | 246,200 | $748,448 | 100.00% | 0.24% |
| 02/24/2025 | 240,000 | $729,600 | 100.00% | 0.23% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Revance Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 266 institutional investors and hedge funds held shares of Revance Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 8.6 M
Beryl Capital Management LLC: 5.94 M
VANGUARD GROUP INC: 5.63 M
FIL Ltd: 4.2 M
ALLIANCEBERNSTEIN L.P.: 3.5 M
Squarepoint Ops LLC: 3.16 M
77.23% of Revance Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 89.15 M shares in the last 24 months. This purchase volume represents approximately $309.35 M in transactions.